HOLLISTON, Mass.--(BUSINESS WIRE)--Oligo Factory, a leading manufacturer of high-quality oligonucleotides at scale, announces today that it is compliant with current Good Manufacturing Practices (GMP) ...
The Food and Drug Administration recently released draft guidance for the industry entitled “Data Integrity and Compliance with CGMP [Current Good Manufacturing Practices].” While the draft is not ...
CARY, N.C., Aug. 13, 2025 /PRNewswire/ -- InstantGMP™, a leading provider of software solutions for FDA and GMP-compliant manufacturing, is excited to announce recent improvements to the GMP ...
This program combines general considerations for Good Manufacturing Practice (GMP) compliance management with the principles of phase-appropriate GMP considerations, with an emphasis on needs of ...
The Dutch authority carrying out GMP inspections, the Health and Youth Care Inspectorate (IGJ), announced it will carry out a series of ...
The revision of Chapter 1 (Quality Management) and Chapter 2 (Personnel) of Part I of the EU guide to GMP to incorporate ICH Q10 brings into sharp focus the management responsibilities for ...
The New Voice of Ukraine on MSN
Ukraine’s drug supply at risk as GMP delays stall imports during wartime shortages
Companies report that overly complex procedures for confirming compliance with Good Manufacturing Practices (GMP) are ...
The "Golden Rules of Being a Successful GMP (Good Manufacturing Practice) Auditor Training Course (Feb 5th - Feb 6th, 2026)" training has been added to ResearchAndMarkets.com's offering. Navigating ...
The regulations for food and drugs in the United States, described in Title 21 of the Code of Federal Regulations (CFR), are critical in ensuring safe and ethical drug administration. Whether you are ...
TORONTO, Canada, December 2, 2025 (EZ Newswire) -- GrowerIQ, opens new tab, a global leader in cannabis compliance and seed-to-sale software, is proud to announce that its core platform has been ...
Confirmation of quality of TxCell's manufacturing platform by ANSM enables regulatory submissions for Ovasave(R) phase IIb clinical study Valbonne, France, June 12, 2014. – TxCell SA (FR0010127662 – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results